Publicação
Targeting miR-155 in triple negative breast cancer via CRISPR/Cas9 delivery using peptide-engineered extracellular vesicles
| Resumo: | Triple negative breast cancer (TNBC) represents a heterogeneous and aggressive subtype of breast cancer, accounting for 10-20% of all cases. It is associated with a poor prognosis due to the absence of effective targetable biomarkers and high metastatic potential. Despite advances in cancer therapy, TNBC remains a challenging condition for clinicians, highlighting the need for novel therapies. Dysregulation of microRNAs (miRNAs) has been implicated in cancer progression, with miR-155, one of the most frequently overexpressed miRNAs in both solid and hematological cancers, being linked to breast cancer development. This study investigated the role of miR-155 in TNBC and explored its potential as a therapeutic target. miR-155 was found to be upregulated in multiple TNBC cell lines, and the CRISPR/Cas9 genome editing system was used to specifically disrupt miR-155 expression. This disruption led to significant effects on TNBC cell biology, including impaired cell proliferation, G2/M cell cycle arrest, reduced cell migration, and activation of the intrinsic apoptosis pathway. Additionally, to enhance CRISPR/Cas9 delivery, extracellular vesicles (EVs) were engineered using a TNBC-specific peptide identified in-house through phage display. These chemically modified EVs demonstrated significantly enhanced uptake by TNBC cells in vivo, confirming their targeted delivery capability. The EVs efficiently encapsulated the CRISPR/Cas9 plasmid, enabling precise gene editing in TNBC cells. Altogether, these findings provide a proof-of-principle for a targeted, precise, and effective delivery approach for CRISPR genome editing in TNBC tumors. |
|---|---|
| Autores principais: | Ferreira, Débora |
| Outros Autores: | Sousa, Diana Andrade; Da Silva, Catarina; Gandarela, Leonor B.; Sousa, Mariana Martins; Rodrigues, L. R. |
| Ano: | 2025 |
| País: | Portugal |
| Tipo de documento: | outro |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Universidade do Minho |
| Idioma: | inglês |
| Origem: | RepositóriUM - Universidade do Minho |
Registos relacionados
image CRISPR/Cas9-mediated knockout of miR-155 for Triple Negative Breast Cancer treatment
por: Sousa, Diana Andrade
Publicado em: (2020)
por: Sousa, Diana Andrade
Publicado em: (2020)
category Potential of exosome-mediated delivery of CRISPR-Cas9 for microRNA-155 targeting in triple negative breast cancer
por: Gonçalves, Catarina Augusta Silva
Publicado em: (2024)
por: Gonçalves, Catarina Augusta Silva
Publicado em: (2024)
image Targeting oncogenic microRNAs in triple negative breast cancer using CRISPR/cas9 approach
por: Sousa, Diana Andrade
Publicado em: (2018)
por: Sousa, Diana Andrade
Publicado em: (2018)
school Extracellular vesicle-mediated drug delivery in triple negative breast cancer
por: Gandarela, Leonor Batista
Publicado em: (2025)
por: Gandarela, Leonor Batista
Publicado em: (2025)
image In silico prediction and design of CRISPR sgRNAs targeting miR-155 for TNBC treatment
por: Sousa, Diana Andrade
Publicado em: (2020)
por: Sousa, Diana Andrade
Publicado em: (2020)
category Targeting oncogenic microRNAs in triple negative breast cancer using a CRISPR/Cas9-based approach
por: Sousa, Diana Andrade
Publicado em: (2020)
por: Sousa, Diana Andrade
Publicado em: (2020)
school Cell-derived extracellular vesicles as a delivery platform towards triple negative breast cancer
por: Gonçalves, Catarina Augusta Silva
Publicado em: (2024)
por: Gonçalves, Catarina Augusta Silva
Publicado em: (2024)
article Matrix Gla protein repression by miR-155 promotes oncogenic signals in breast cancer MCF-7 cells
por: Tiago, Daniel
Publicado em: (2016)
por: Tiago, Daniel
Publicado em: (2016)
category Selection of novel peptides homing alternative targets in triple negative breast cancer
por: Ferreira, Débora
Publicado em: (2017)
por: Ferreira, Débora
Publicado em: (2017)
category Peptide-mediated targeted delivery system towards triple negative breast cancer treatment
por: Ferreira, Débora
Publicado em: (2020)
por: Ferreira, Débora
Publicado em: (2020)
school CRISPR-Cas9 mutagenesis of the zebrafish foxm1
por: Carvalho, Ana Leonor Azevedo dos Santos
Publicado em: (2018)
por: Carvalho, Ana Leonor Azevedo dos Santos
Publicado em: (2018)
category Smart extracellular vesicles for targeted therapy in breast cancer
por: Ferreira, Débora
Publicado em: (2025)
por: Ferreira, Débora
Publicado em: (2025)
school Peptide-mediated targeted delivery system towards triple negative breast cancer treatment
por: Ferreira, Débora Carina Gonçalves Abreu
Publicado em: (2021)
por: Ferreira, Débora Carina Gonçalves Abreu
Publicado em: (2021)
school Editing of the ADORA2A gene by CRISPR/Cas9
por: Costa, Raquel Lagoa Madruga da
Publicado em: (2021)
por: Costa, Raquel Lagoa Madruga da
Publicado em: (2021)
article Cx43‐mediated sorting of miRNAs into extracellular vesicles
por: Martins Marques, Tânia
Publicado em: (2022)
por: Martins Marques, Tânia
Publicado em: (2022)
article CRISPR/Cas9 a simple, inexpensive and effective technique for gene editing
por: Ferreira, Patrick
Publicado em: (2022)
por: Ferreira, Patrick
Publicado em: (2022)
book CRISPR-CAS9 em plantas: desafios éticos, científicos e oportunidades
por: Choupina, Altino
Publicado em: (2024)
por: Choupina, Altino
Publicado em: (2024)
article Cellular delivery of CRISPR/Cas9 plasmid using multivalent cationic liposomes
por: Sousa, Diana Andrade
Publicado em: (2021)
por: Sousa, Diana Andrade
Publicado em: (2021)
article CRISPR-Cas9: a powerful tool to efficiently engineer Saccharomyces cerevisiae
por: Costa, João Manuel Rainha
Publicado em: (2021)
por: Costa, João Manuel Rainha
Publicado em: (2021)
article CRISPR/Cas9‐mediated genome editing: from basic research to translational medicine
por: Jacinto, Filipe
Publicado em: (2020)
por: Jacinto, Filipe
Publicado em: (2020)
category Optimizing CRISPR/Cas9 for high-expression genome loci in industrial yeast strains
por: Carvalho, Margarida
Publicado em: (2017)
por: Carvalho, Margarida
Publicado em: (2017)
article CRISPR‑Cas9 engineered Saccharomyces cerevisiae for endolysin delivery to combat Listeria monocytogenes
por: Sáez Moreno, David
Publicado em: (2025)
por: Sáez Moreno, David
Publicado em: (2025)
school Androgen receptor expression in triple-negative breast cancer
por: Rodrigues, Filipa Nascimento
Publicado em: (2014)
por: Rodrigues, Filipa Nascimento
Publicado em: (2014)
school Correction of sickle-cell anemia using CRISPR-Cas9 system in hematopoietic stem cells
por: Draiblate, Beatriz Lopes
Publicado em: (2020)
por: Draiblate, Beatriz Lopes
Publicado em: (2020)
article Two CRISPR/Cas9-mediated methods for targeting complex insertions, deletions, or replacements in mouse
por: Pineault, Kyriel M.
Publicado em: (2019)
por: Pineault, Kyriel M.
Publicado em: (2019)
article Circulating miRNAs are associated with the systemic extent of atherosclerosis : novel observations for miR-27b and miR-146
por: Pereira da Silva, Tiago
Publicado em: (2021)
por: Pereira da Silva, Tiago
Publicado em: (2021)
article Surface engineering of exosomes led to an enhanced uptake by triple negative breast cancer cells
por: Ferreira, Débora
Publicado em: (2021)
por: Ferreira, Débora
Publicado em: (2021)
article Evaluation of the delivery of an anti-Listeria endolysin via CRISPR-Cas9 engineered probiotic Saccharomyces boulardii
por: Sáez, David
Publicado em: (2026)
por: Sáez, David
Publicado em: (2026)
article In Vitro CRISPR/Cas9 Transfection and Gene-Editing Mediated by Multivalent Cationic LiposomeDNA Complexes
por: Sousa, Diana Andrade
Publicado em: (2022)
por: Sousa, Diana Andrade
Publicado em: (2022)
school LDL favours metastatic spread of triple negative breast cancer
por: Santos, Miguel Esteves de Oliveira
Publicado em: (2019)
por: Santos, Miguel Esteves de Oliveira
Publicado em: (2019)
article Triple negative breast cancer: nanosolutions for a big challenge
por: Mendes, T.
Publicado em: (2015)
por: Mendes, T.
Publicado em: (2015)
school Drug-loaded magnetoliposomes for triple negative breast cancer therapy
por: Andrade, Raquel Gaudência Dias
Publicado em: (2026)
por: Andrade, Raquel Gaudência Dias
Publicado em: (2026)
category Engineered exosome-mediated delivery of RNAi therapeutics towards triple negative breast cancer therapy
por: Ferreira, Débora
Publicado em: (2021)
por: Ferreira, Débora
Publicado em: (2021)
article Overexpression of circulating MiR-30b-5p identifies advanced breast cancer
por: Estevão-Pereira, Helena
Publicado em: (2019)
por: Estevão-Pereira, Helena
Publicado em: (2019)
article Selection of novel peptides homing the 4T1 CELL line: exploring alternative targets for triple negative breast cancer
por: Silva, V.
Publicado em: (2016)
por: Silva, V.
Publicado em: (2016)
article MiR-146b negatively regulates migration and delays progression of T-cell acute lymphoblastic leukemia
por: Correia, Nádia
Publicado em: (2016)
por: Correia, Nádia
Publicado em: (2016)
groups miR-181a negatively regulates human γδ T cell differentiation into anti-tumor effectors
por: Gordino, Gisela
Publicado em: (2019)
por: Gordino, Gisela
Publicado em: (2019)
category Non-viral delivery of CRISPR/Cas9 DNA for gene editing via multivalent cationic liposome system
por: Sousa, Diana Andrade
Publicado em: (2022)
por: Sousa, Diana Andrade
Publicado em: (2022)
category CRISPR-Cas9 based strategy to engineer Saccharomyces cerevisiae towards the production of curcumin from ferulic acid
por: Costa, João Manuel Rainha
Publicado em: (2019)
por: Costa, João Manuel Rainha
Publicado em: (2019)
article Therapeutic implications of the molecular and immune landscape of triple-negative breast cancer
por: Gregório, Ana C.
Publicado em: (2018)
por: Gregório, Ana C.
Publicado em: (2018)
Atividades financiadas
progress_activity Carregando projetos financiados...
Registos relacionados
-
image CRISPR/Cas9-mediated knockout of miR-155 for Triple Negative Breast Cancer treatment
por: Sousa, Diana Andrade
Publicado em: (2020) -
category Potential of exosome-mediated delivery of CRISPR-Cas9 for microRNA-155 targeting in triple negative breast cancer
por: Gonçalves, Catarina Augusta Silva
Publicado em: (2024) -
image Targeting oncogenic microRNAs in triple negative breast cancer using CRISPR/cas9 approach
por: Sousa, Diana Andrade
Publicado em: (2018) -
school Extracellular vesicle-mediated drug delivery in triple negative breast cancer
por: Gandarela, Leonor Batista
Publicado em: (2025) -
image In silico prediction and design of CRISPR sgRNAs targeting miR-155 for TNBC treatment
por: Sousa, Diana Andrade
Publicado em: (2020)